Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification
Laroni, A., Giacomazzi, C. G., Grimaldi, L., Gallo, P., Sormani, M. P., Bertolotto, A., McDermott, J. L., Gandoglia, I., Martini, I., Vitello, G., Rinaldi, F., Barzon, L., Militello, V., Pizzorno, M., Bandini, F., Capello, E., Palù, G., Uccelli, A., Mancardi, G. L., Varnier, O. E.
Published in Journal of neuroimmune pharmacology (01.09.2012)
Published in Journal of neuroimmune pharmacology (01.09.2012)
Get full text
Journal Article
A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
Gugliandolo, Agnese, Longo, Federica, Marrosu, Maria Giovanna, Mancardi, Giovanni Luigi, Gandoglia, Ilaria, Melis, Maurizio, Lo Giudice, Fabrizio, Bramanti, Placido, Mazzon, Emanuela
Published in Therapeutics and clinical risk management (01.01.2018)
Published in Therapeutics and clinical risk management (01.01.2018)
Get full text
Journal Article